Erasmus MC

Running trials

• Not yet recruiting

  Hepatic arterial infusion versus intravenous oxaliplatin in a safety, feasibility, and pharmacokinetic study of liver-dominant malignancies – ARTEMIS OXYS-I trial

  2026-527509-39-01· PHASE1 PHASE2· Source

• Recruiting

  A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

  NCT07623200· PHASE3· Source

• Recruiting

  European Study of the BrioVAD Heart Pump for Advanced Heart Failure

  NCT07252531· Source

• Recruiting

  Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer

  NCT07645625· PHASE4· Source

• Recruiting

  CBCT Guided Markerless SBRT for Renal Cell Cancer

  NCT07402109· Source

• Recruiting

  Clinical Impact of Using IMPROVE to Select Patients for Carotid Revascularisation

  NCT07556887· Source

• Not yet recruiting

  Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

  NCT07368985· PHASE2· Source

• Recruiting

  Higher Radiation Dose to the Tumor May Help Avoid Surgery in Rectal Cancer Patients

  NCT07616297· Source

• Recruiting

  A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, in People With a Heart Attack

  NCT07301034· PHASE3· Source

• Enrolling by invitation

  Multivitamin Impact on Micronutrient Status in GLP-1 Users: A Randomized Trial

  NCT07234916· Source

• Recruiting

  Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

  NCT07123155· PHASE2· Source

• Recruiting

  ctDNA-Based Adjuvant Chemotherapy for High-Risk Rectal Cancer

  NCT07188025· PHASE3· Source

• Recruiting

  INTERACT Stomach-II

  NCT07133490· PHASE2· Source

• Active, not recruiting

  Durability of Pulmonary Vein Isolation Using a Variable-Loop Biphasic Pulsed Field Ablation Catheter in Patients With Paroxysmal Atrial Fibrillation

  NCT07236619· Source

• Recruiting

  Accuracy and Sustainability of SCALE-EYE Evaluation for Measuring Reliable Polyp Size

  NCT07005453· Source

• Recruiting

  Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension

  NCT07115953· Source

• Recruiting

  A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors

  NCT07169734· PHASE1 PHASE2· Source

• Recruiting

  Prospective Data Collection Initiative on Thoracic Malignancies

  NCT06996249· Source

• Recruiting

  Smart Measurement of Circulating Tumor DNA

  NCT06989814· Source

• Recruiting

  Towards Cure Via Only Ultra-short ICB in CSCC

  NCT06823479· PHASE2· Source

• Recruiting

  Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

  NCT06921785· PHASE3· Source

• Active, not recruiting

  Thermotherapy for Locally Advanced Head and Neck Cancer

  NCT06761937· PHASE1· Source

• Recruiting

  PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

  NCT06855329· Source

• Recruiting

  Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

  NCT06754904· Source

• Recruiting

  An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

  NCT06951217· PHASE2· Source

• Recruiting

  Diuretic Testing in Chronic Kidney Disease

  NCT06841692· Source

• Recruiting

  Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

  NCT06643286· Source

• Recruiting

  A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

  NCT06644781· PHASE3· Source

• Active, not recruiting

  REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure

  NCT06557798· Source

• Not yet recruiting

  Evaluation of Gixam's Efficacy Predicting Pre-cancerous Colorectal Polyps and Colorectal Cancer

  NCT06688110· Source

• Recruiting

  Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI

  NCT07121842· Source

• Recruiting

  Urinary Tubular Biomarkers for Chronic Kidney Disease

  NCT06732349· Source

• Recruiting

  Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer

  NCT06308510· Source

• Recruiting

  The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma

  NCT06355427· PHASE2 PHASE3· Source

• Recruiting

  Esophageal Self-expandable Metal Stent for Malignant Strictures: a Safety and Efficacy Study

  NCT06364553· Source

• Active, not recruiting

  Mobile Screening for Major Depressive Disorder in Adults From an Ethnically and Socioeconomically Diverse Population.

  NCT05989412· Source

• Recruiting

  Spinal Cord Monitoring in Multiple Sclerosis

  NCT06827834· Source

• Active, not recruiting

  HOPE at Heart (HOPE) of Donor Hearts After Circulatory Death (DCD) Using the XVIVO Heart Assist Transport System.

  NCT06485596· Source

• Not yet recruiting

  FET-PET-Guided Management of Pseudoprogression in Glioblastoma

  NCT06480721· Source

• Recruiting

  Safety and pharmacokinetics of antipsychotics in children 2: Studying TDM in an RCT

  NCT05146245· PHASE4· Source

• Recruiting

  Stereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma

  NCT06493734· Source

• Not yet recruiting

  Clinical Effects of Intra-aortic Balloon Support in Early Acute Coronary Syndrome and Non-Acute Coronary Syndrome Related Cardiogenic Shock

  NCT06414187· Source

• Active, not recruiting

  Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma

  NCT06183489· PHASE2· Source

• Recruiting

  To Quantify the Impact of Addition of the GAAD Score to Imaging in Patients with Chronic Liver Disease Eligible for HCC Surveillance.

  NCT06601231· Source

• Recruiting

  Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

  NCT07260435· PHASE3· Source

• Recruiting

  Data Collection in Lutetium Treated Prostate Cancer: Recording of Progression and Tumor Characteristics

  NCT06260410· Source

• Active, not recruiting

  RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

  NCT05883631· Source

• Recruiting

  Safety and Efficacy of Ultrasound Renal Denervation in Kidney Transplantation Patients With Uncontrolled Hypertension

  NCT05934383· Source

• Enrolling by invitation

  Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction

  NCT06671418· PHASE3· Source

• Recruiting

  Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors

  NCT06301945· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer8 recruiting
• Liver and biliary tract cancer8 recruiting
• Childhood cancers7 recruiting
• Gastric and esophageal cancer6 recruiting
• Glioblastoma5 recruiting
• Lung cancer4 recruiting
• Bladder cancer3 recruiting
• Chronic kidney disease3 recruiting
• Heart failure3 recruiting
• Melanoma3 recruiting
• Prostate cancer3 recruiting
• Cervical cancer2 recruiting
• Coronary artery disease2 recruiting
• Head and neck cancer2 recruiting
• High blood pressure2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Kidney cancer2 recruiting
• Mesothelioma2 recruiting
• Neuroendocrine tumours2 recruiting
• Pancreatic cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukemia1 recruiting
• Autism1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Follicular lymphoma1 recruiting
• Mantle cell lymphoma1 recruiting
• Multiple sclerosis1 recruiting
• Myelodysplastic syndromes1 recruiting
• Myeloproliferative neoplasms1 recruiting
• Obesity1 recruiting
• Ovarian cancer1 recruiting
• Pompe disease1 recruiting
• Stroke1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life

  NCT06427122· Source

• Completed

  The Effectiveness of Adding Braun Anastomosis to Standard Child Reconstruction After Pancreatoduodenectomy

  NCT05709197· Source

• Completed

  PriskA Pilot Study

  NCT05785507· Source

• Completed

  Safety and Tolerability of AC01 in patients with heart failure

  2022-500347-20-00· PHASE1 PHASE2· Source

• Completed

  AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation

  NCT05481359· Source

• Completed

  Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

  NCT05678218· Source

• Completed

  Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer

  NCT04191460· PHASE2· Source

• Completed

  Feasibility, Reliability, and Satisfaction of CEA Using Home Based (Automated) Capillary Blood Sampling

  NCT05646030· Source

• Completed

  Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma

  NCT05449366· PHASE1 PHASE2· Source

• Completed

  A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

  NCT04984356· PHASE1· Source

• Completed

  A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

  NCT05053139· PHASE3· Source

• Completed

  Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization

  NCT04931771· Source

• Completed

  PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations

  NCT05854901· Source

• Completed

  The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC

  NCT05902260· Source

• Completed

  Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 3)

  NCT04880434· PHASE2· Source

• Completed

  Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

  NCT04644237· PHASE2· Source

• Completed

  Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

  NCT04524442· PHASE4· Source

• Completed

  Periprocedural Continuation Versus Interruption of Oral Anticoagulant Drugs During Transcatheter Aortic Valve Implantation (POPular PAUSE TAVI)

  NCT04437303· PHASE4· Source

• Completed

  Reduced Anticoagulation Targets in ECLS (RATE)

  NCT04536272· PHASE3· Source

• Completed

  Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

  NCT04340076· PHASE4· Source

• Completed

  A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer

  NCT04256421· PHASE3· Source

• Completed

  iCLAS™ for Persistent Atrial Fibrillation

  NCT04061603· Source

• Completed

  Study of DF1001 in Patients With Advanced Solid Tumors

  NCT04143711· PHASE1 PHASE2· Source

• Completed

  A Phase 2 Study to Evaluate Safety of Long-term AL001 Dosing in Frontotemporal Dementia (FTD) Patients (INFRONT-2)

  NCT03987295· PHASE2· Source

• Completed

  A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

  NCT03535740· PHASE2· Source

• Completed

  Long Term Extension Trial of Setmelanotide

  NCT03651765· PHASE2 PHASE3· Source

• Completed

  Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)

  NCT03112174· PHASE3· Source

• Completed

  Comparison of Pom and Dex in Subjects With RRMM Previously Treated With Len and a PI Dara/Pom/Dex vs Pom/Dex

  NCT03180736· PHASE3· Source

• Completed

  Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

  NCT02973789· PHASE3· Source

• Completed

  Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies

  NCT02576496· PHASE1· Source

• Completed

  A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)

  NCT02614066· PHASE1 PHASE2· Source

• Completed

  New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement

  NCT02329080· PHASE2· Source

• Completed

  Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

  NCT02162563· PHASE3· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· PHASE3· Source

• Completed

  Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer

  NCT01658930· Source

Trial sites

• Erasmus MC0 trials
• Erasmus MC2 trials
• Erasmus MC107 trials
• Erasmus MC, University Medical Center Rotterdam2 trials
• Erasmus Medical Center Rotterdam0 trials
• Erasmus University Medical Center27 trials
• Erasmus MC0 trials
• Erasmus MC0 trials
• Erasmus MC2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke380 works · 4 trials
• Heart failure377 works · 10 trials
• Obesity306 works · 2 trials
• Prostate cancer256 works · 4 trials
• Lung cancer246 works · 11 trials
• Colorectal cancer187 works · 12 trials
• Atrial fibrillation170 works · 4 trials
• Type 2 diabetes146 works · 0 trials
• Coronary artery disease136 works · 5 trials
• Asthma133 works · 0 trials
• Pancreatic cancer117 works · 3 trials
• Melanoma115 works · 5 trials
• Rheumatoid arthritis115 works · 1 trials
• Chronic kidney disease114 works · 5 trials
• Acute myeloid leukemia93 works · 1 trials
• Cervical cancer87 works · 3 trials
• Type 1 diabetes85 works · 0 trials
• Gastric and esophageal cancer81 works · 6 trials
• Hypertrophic cardiomyopathy75 works · 1 trials
• Crohn's disease73 works · 0 trials
• Frontotemporal dementia73 works · 2 trials
• Head and neck cancer69 works · 5 trials
• Glioblastoma65 works · 6 trials
• Schizophrenia60 works · 0 trials
• Migraine58 works · 0 trials
• Idiopathic pulmonary fibrosis53 works · 2 trials
• Autism51 works · 1 trials
• COPD50 works · 1 trials
• Cystic fibrosis49 works · 0 trials
• Depression47 works · 1 trials